387 related articles for article (PubMed ID: 28748519)
1. Obstetric antiphospholipid syndrome and long term arterial thrombosis risk.
Drozdinsky G; Hadar E; Shmueli A; Gabbay-Benziv R; Shiber S
J Thromb Thrombolysis; 2017 Oct; 44(3):371-375. PubMed ID: 28748519
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients.
Lefèvre G; Lambert M; Bacri JL; Dubucquoi S; Quemeneur T; Caron C; Launay D; Houfflin-Debarge V; Hachulla E; Kyndt X; Subtil D; Hatron PY
Lupus; 2011 Jul; 20(8):861-5. PubMed ID: 21546412
[TBL] [Abstract][Full Text] [Related]
3. Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study.
Gris JC; Bouvier S; Molinari N; Galanaud JP; Cochery-Nouvellon E; Mercier E; Fabbro-Peray P; Balducchi JP; Marès P; Quéré I; Dauzat M
Blood; 2012 Mar; 119(11):2624-32. PubMed ID: 22147897
[TBL] [Abstract][Full Text] [Related]
4. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
Marai I; Levi Y; Godard G; Shoenfeld Y
Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
[TBL] [Abstract][Full Text] [Related]
5. Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome.
Fujieda Y; Atsumi T; Amengual O; Odani T; Otomo K; Kato M; Oku K; Kon Y; Horita T; Yasuda S; Koike T
Lupus; 2012 Dec; 21(14):1506-14. PubMed ID: 22936124
[TBL] [Abstract][Full Text] [Related]
6. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
7. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF
Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid syndrome.
Cervera R
Thromb Res; 2017 Mar; 151 Suppl 1():S43-S47. PubMed ID: 28262233
[TBL] [Abstract][Full Text] [Related]
9. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA;
Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
de Jesús GR; Sciascia S; Andrade D; Barbhaiya M; Tektonidou M; Banzato A; Pengo V; Ji L; Meroni PL; Ugarte A; Cohen H; Branch DW; Andreoli L; Belmont HM; Fortin PR; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Nascimento IS; Rosa R; Erkan D; Levy RA;
BJOG; 2019 Apr; 126(5):656-661. PubMed ID: 30222236
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center.
Serrano R; Pons-Estel GJ; Espinosa G; Quintana RM; Reverter JC; Tassies D; Monteagudo J; Cervera R
Lupus; 2020 Aug; 29(9):1050-1059. PubMed ID: 32536318
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for arterial thrombosis in antiphospholipid syndrome.
Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic risk in the antiphospholipid syndrome.
Lim W
Semin Thromb Hemost; 2014 Oct; 40(7):741-6. PubMed ID: 25299926
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
[TBL] [Abstract][Full Text] [Related]
15. Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative.
Coloma Bazán E; Donate López C; Moreno Lozano P; Cervera R; Espinosa G
Immunol Res; 2013 Jul; 56(2-3):358-61. PubMed ID: 23568055
[TBL] [Abstract][Full Text] [Related]
16. Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies.
Owaidah TM; Qurashi FH; Al Nounou RM; Al Zahrani H; Al Mussa A; Tbakhi AI; Al Daama S; Elkum N; Roberts GT
Hematology; 2003 Aug; 8(4):249-57. PubMed ID: 12911943
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of risk factors in development of thrombosis in patients with antiphospholipid syndrome].
Li R; Zhou YS; Jia Y; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):788-91. PubMed ID: 23073594
[TBL] [Abstract][Full Text] [Related]
19. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
20. The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics.
Tonello M; Calligaro A; Favaro M; Del Ross T; Veronese P; Salvan E; Gervasi MT; Ruffatti A
Arch Gynecol Obstet; 2021 Feb; 303(2):455-461. PubMed ID: 32880711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
